Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NETs”

144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 144 results

Large-scale testing (Phase 3)Study completedNCT00409370
What this trial is testing

Trial of Safety Nets In Hospitalized Patients

Who this might be right for
DeliriumAgitated BehaviorAlcohol Withdrawl+2 more
Griffin Hospital 60
Early research (Phase 1)Study completedNCT03879694
What this trial is testing

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Lung Atypical Carcinoid TumorLung Typical Carcinoid TumorMetastatic Pancreatic Neuroendocrine Tumor
Roswell Park Cancer Institute 19
Not applicableStudy completedNCT05427032
What this trial is testing

HRQoL During PRRT in Patients With NETs

Who this might be right for
Neuroendocrine TumorsQuality of LifePeptide Receptor Radionuclide Therapy
Uppsala University 756
Not applicableLooking for participantsNCT07264556
What this trial is testing

Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery

Who this might be right for
Colorectal CancerOpioid-free AnesthesiaNETs
Fudan University 90
Large-scale testing (Phase 3)Looking for participantsNCT07165886
What this trial is testing

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 298
Large-scale testing (Phase 3)Active Not RecruitingNCT07119242
What this trial is testing

Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs

Who this might be right for
NETs
HTA Co., Ltd. 95
Not applicableStudy completedNCT03817866
What this trial is testing

Chromogranin A as Blood Marker in Cancer Patients

Who this might be right for
Gastric NeoplasmsPancreatic NeoplasmsSmall Intestinal Neoplasms+1 more
Brahms AG 175
Not applicableLooking for participantsNCT05711173
What this trial is testing

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Who this might be right for
Venous ThrombosesThromboembolic DiseaseNeutrophil Extracellular Trap Formation+1 more
University Hospital, Bordeaux 150
Not applicableUnknownNCT01491230
What this trial is testing

Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Childhood Cancer
Tel-Aviv Sourasky Medical Center 50
Early research (Phase 1)Study completedNCT01590199
What this trial is testing

Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs

Who this might be right for
Neuroendocrine Tumors
Novartis Pharmaceuticals 18
Early research (Phase 1)Ended earlyNCT02943733
What this trial is testing

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

Who this might be right for
Neuroendocrine TumorsNeoplasmsCancer+1 more
University of Wisconsin, Madison 18
Not applicableLooking for participantsNCT05919758
What this trial is testing

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

Who this might be right for
NeoplasmsAppendix Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,000
Not applicableStudy completedNCT04318691
What this trial is testing

Netosis in Determination of Respiratory Infection Severity

Who this might be right for
Respiratory Infection
Assistance Publique - Hôpitaux de Paris 80
Not applicableActive Not RecruitingNCT03498040
What this trial is testing

Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

Who this might be right for
Carcinoid Heart Disease
Hospices Civils de Lyon 670
Not applicableStudy completedNCT04230161
What this trial is testing

Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Rwanda

Who this might be right for
Malaria
PATH 3,502
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784
What this trial is testing

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more
University of Washington 20
Post-approval studies (Phase 4)Study completedNCT01595009
What this trial is testing

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

Who this might be right for
Neuroendocrine Tumors
Novartis Pharmaceuticals 246
Not applicableStudy completedNCT04550026
What this trial is testing

Cardiovascular Effects of Heated Tobacco Products (HTP)

Who this might be right for
Heated Tobacco ProductsMicrocirculationThrombosis+4 more
Karolinska Institutet 25
Not applicableNot Yet RecruitingNCT07358221
What this trial is testing

Impact of Different Cardioplegia Solutions on Indicators of Myocardial Injury During Coronary Surgery

Who this might be right for
Coronary Artery Bypass Grafting (CABG) SurgeryMyocardial Protection
Damascus University 30
Testing effectiveness (Phase 2)Study completedNCT02299089
What this trial is testing

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Who this might be right for
AcromegalyNeuroendocrine Tumors
Camurus AB 12
Load More Results